Related Experiment Video
Updated: Jun 13, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
HSP90 and its inhibitors.
Huifang Hao1, Yoshio Naomoto, Xiaohong Bao
1Department of Gastroenterological Surgery, Transplant and Surgical Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Heat shock protein 90 (HSP90) chaperones are vital for cell survival and cancer progression. Targeting HSP90 with compounds offers a promising strategy for cancer therapy by disrupting essential protein complexes.
Area of Science:
- Molecular Biology
- Biochemistry
- Oncology
Background:
- Heat shock protein 90 (HSP90) is a highly conserved molecular chaperone family found in diverse organisms.
- HSP90 plays critical roles in maintaining cellular homeostasis, including protein quality control, signal transduction, and apoptosis.
- Dysregulation of HSP90 function is implicated in the progression of various malignant diseases.
Purpose of the Study:
- To review the essential functions of HSP90 molecular chaperones.
- To highlight the role of HSP90 in cancer progression.
- To discuss the therapeutic potential of targeting HSP90 in cancer treatment.
Main Methods:
- Literature review of HSP90 functions and roles in cancer.
- Analysis of HSP90's ATP-dependent mechanism.
- Examination of natural and synthetic compounds targeting the HSP90-client protein complex.
Main Results:
- HSP90 proteins are essential for the conformational stability and function of numerous client proteins that regulate cell survival, proliferation, and apoptosis.
- HSP90's ATP-binding and hydrolysis cycle drives client protein folding and maturation.
- Disruption of the ATP-HSP90-client protein complex by various compounds is a key mechanism for potential cancer therapies.
Conclusions:
- HSP90 chaperones are crucial for cellular functions and are frequently overexpressed or activated in cancer cells.
- Targeting HSP90 represents a viable therapeutic strategy for cancer treatment.
- Further research into HSP90 inhibitors could lead to novel anti-cancer drugs.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation

